A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study
Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Study is a multicenter, two-part, open-label phase II study in adults, evaluating the safety
and long-term efficacy of PF-06473871 one year after surgical revision and treatment with
PF-06473871.